Addition of anticholinergic solution prolongs bronchodilator effect of β2agonists in patients with chronic obstructive pulmonary disease
DC Levin, KS Little, KR Laughlin, JM Galbraith… - The American journal of …, 1996 - Elsevier
A randomized, double-blind, placebo-controlled clinical trial was designed to assess the
safety, efficacy, and duration of the bronchodilation resulting from the addition of 500 μg of …
safety, efficacy, and duration of the bronchodilation resulting from the addition of 500 μg of …
Addition of anticholinergic solution prolongs bronchodilator effect of β2agonists in patients with chronic obstructive pulmonary disease
DC Levin, KS Little, KR Laughlin… - The American Journal …, 1996 - amjmed.com
A randomized, double-blind, placebo-controlled clinical trial was designed to assess the
safety, efficacy, and duration of the bronchodilation resulting from the addition of 500 μg of …
safety, efficacy, and duration of the bronchodilation resulting from the addition of 500 μg of …
[引用][C] Addition of anticholinergic solution prolongs bronchodilator effect of β2 agonists in patients with chronic obstructive pulmonary disease
DC LEVIN, KS LITTLE, K MCFARLAND… - … American journal of …, 1996 - pascal-francis.inist.fr
Author LEVIN, D. C 1; LITTLE, K. S 1; MCFARLAND, K; PETTY, T. L; SILVERS, W;
RENNARD, S. I; MUELLER, M; REPSHER, L. H; ZUWALLACK, R. L; VALE, R; LAUGHLIN …
RENNARD, S. I; MUELLER, M; REPSHER, L. H; ZUWALLACK, R. L; VALE, R; LAUGHLIN …
Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease
DC Levin, KS Little, KR Laughlin… - … journal of medicine, 1996 - pubmed.ncbi.nlm.nih.gov
A randomized, double-blind placebo-controlled clinical trial was designed to assess the
safety, efficacy, and duration of the bronchodilation resulting from the addition of 500 …
safety, efficacy, and duration of the bronchodilation resulting from the addition of 500 …
Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease.
DC Levin, KS Little, KR Laughlin… - The American Journal …, 1996 - europepmc.org
A randomized, double-blind placebo-controlled clinical trial was designed to assess the
safety, efficacy, and duration of the bronchodilation resulting from the addition of 500 …
safety, efficacy, and duration of the bronchodilation resulting from the addition of 500 …
Addition of anticholinergic solution prolongs bronchodilator effect of β2agonists in patients with chronic obstructive pulmonary disease
DC Levin, KS Little, KR Laughlin, JM Galbraith… - The American Journal of …, 1996 - infona.pl
A randomized, double-blind, placebo-controlled clinical trial was designed to assess the
safety, efficacy, and duration of the bronchodilation resulting from the addition of 500 μg of …
safety, efficacy, and duration of the bronchodilation resulting from the addition of 500 μg of …
Addition of anticholinergic solution prolongs bronchodilator effect of β2 agonists in patients with chronic obstructive pulmonary disease
DC Levin, KS Little, KR Laughlin… - American Journal of …, 1996 - experts.nebraska.edu
A randomized, double-blind, placebo-controlled clinical trial was designed to assess the
safety, efficacy, and duration of the bronchodilation resulting from the addition of 500 μg of …
safety, efficacy, and duration of the bronchodilation resulting from the addition of 500 μg of …